Tatva Chintan Pharma Chem Q4FY22 and Year Ended result : Profit fall by 17.10% to ₹17.5 Cr YoY

Net Profit of ₹95.87 crore in the financial year ended on March 31, 2022 as against ₹52.26 crore for the financial year ended on March 31, 2021. The PAT surges up by 83.44%

logo credit- tatva chintan pharma chem
article continues after this advertisement

Tatva Chintan Pharma Chem Limited (“Tatva Chintan or TCPCL”) is leading specialty chemicals manufacturing company incorporated in 1996 as a private limited company, having registered office at Ankleshwar, Gujarat, India. The company has posted its Q4F22 and year ended financial results today, the details are as below :

(I) Audited Consolidated Financial Results for Quarter Ended (YoY comparison):

The company has reported, a consolidated Total Income of ₹98.85 crore in the quarter ended on March 31, 2022 as against ₹111.25 crore in the corresponding quarter ended last year on Mar 31, 2021, decreased by 11.14%.

The company has posted a consolidated Net Profit of ₹17.5 crore in the quarter ended on March 31, 2022 as against ₹21.11 crore in the corresponding quarter ended in last year on Mar 31, 2021. The PAT surges down by 17.10%.

The status of the EPS of the company stood at ₹7.9 as on March 31, 2022 compared to the previous quarter ended on Mar 31, 2021 which was ₹10.51, down by 24.83%.

₹*Mar 31, 2022Dec 31, 21Mar 31, 21
Total Income98.85109.23111.25
Total Expenses79.9083.7687.01
PBT /(Loss)18.9725.4624.23
Total Tax /(credit)1.462.663.12
PAT /(Loss)17.522.821.11
*figures are in Crores

(II) Audited Consolidated Financial Result details for the Year Ended :

The company has reported, a consolidated Total Income of ₹442.54 crore in the financial year ended on March 31, 2022 as against ₹305.55 crore for the financial year ended on Mar 31, 2021, increased by 44.83%.

The company has posted a consolidated Net Profit of ₹95.87 crore in the financial year ended on March 31, 2022 as against ₹52.26 crore for the financial year ended on March 31, 2021. The PAT surges up by 83.44%.

The status of the EPS of the company stood at ₹44.59 as on March 31, 2022 compared to the previous year ended on March 31, 2021 which was ₹26.02, up by 71.30%.

₹*Mar 31, 2022 (FY22)Mar 31, 2021 (FY21)
Total Income442.54305.55
Total Expenses338.42244.86
PBT /(Loss)104.1260.69
Total Tax /(credit)8.248.43
PAT /(Loss)95.8752.26
*figures are in Crores
Market Times

Shares of Tatva Chintan Pharma Chem Ltd was last traded in BSE at ₹2476.25 as compared to the previous close of ₹2496.25. The total number of shares traded during the day was 1712 in over 251 trades.

The stock of Tatva Chintan Pharma Chem last hit in BSE,

  • Intraday High of ₹ 2491.00
  • Intraday low of ₹ 2458.10